Analyzing...
Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024 In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, has been placed on the Company’s website at https://www.torrentpharma.com/pdf/investors/TorrentPharma-Earnings-May24-2024.pdf Thanking you,